Amgen gets Amjevita label update; registers Phase 3 MariTide trial against semaglutideNov 6Weekly roundup, 5 itemsadalimumab-attoAmgenUpdated
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Vanderbilt registers Phase 2 toripalimab trial in esophageal cancer, backed by CoherusSep 25Weekly roundup, 2 itemsadalimumab-aqvhadalimumab-atto